These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 2973791

  • 1. Hemodynamic and atrial natriuretic peptide responses to fluid removal and reinfusion in hemodialysis patients.
    Petersen J, Li CC, Bishop-Abney N, Seniw CM.
    ASAIO Trans; 1988; 34(3):509-11. PubMed ID: 2973791
    [Abstract] [Full Text] [Related]

  • 2. [Clinical relevance of the determination of plasma atrial natriuretic peptide in children with chronic renal failure].
    Rascher W, Bald M, Kröner F, Tulassay T, Müller-Wiefel DE.
    Z Kardiol; 1988; 77 Suppl 2():61-4. PubMed ID: 2970176
    [Abstract] [Full Text] [Related]

  • 3. Central blood volume, atrial natriuretic peptide and intermittent hemodialysis.
    Wallin CJ, Rossi P, Jacobson SH, Leksell LG.
    Scand J Urol Nephrol; 2004; 38(1):78-84. PubMed ID: 15204432
    [Abstract] [Full Text] [Related]

  • 4. Plasma natriuretic peptides and cardiac volume during acute changes in intravascular volume in haemodialysis patients.
    Corboy JC, Walker RJ, Simmonds MB, Wilkins GT, Richards AM, Espiner EA.
    Clin Sci (Lond); 1994 Dec; 87(6):679-84. PubMed ID: 7874859
    [Abstract] [Full Text] [Related]

  • 5. N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment.
    Franz M, Woloszczuk W, Hörl WH.
    Kidney Int; 2000 Jul; 58(1):374-83. PubMed ID: 10886584
    [Abstract] [Full Text] [Related]

  • 6. Change in plasma immunoreactive atrial natriuretic peptide during sequential ultrafiltration and haemodialysis.
    Wilkins MR, Wood JA, Adu D, Lote CJ, Kendall MJ, Michael J.
    Clin Sci (Lond); 1986 Aug; 71(2):157-60. PubMed ID: 2941209
    [Abstract] [Full Text] [Related]

  • 7. Changes in plasma atrial natriuretic peptide during hemodialysis: mechanism of elevated levels in patients with chronic renal failure.
    Takagi T, Nishikawa M, Inada M.
    Endocr J; 1993 Apr; 40(2):257-61. PubMed ID: 7951512
    [Abstract] [Full Text] [Related]

  • 8. Plasma atrial natriuretic peptide during hemodialysis with or without fluid removal.
    Shiota J, Kubota M, Hamada C, Koide H.
    Nephron; 1990 Apr; 55(3):283-6. PubMed ID: 2142515
    [Abstract] [Full Text] [Related]

  • 9. Changes in brain natriuretic peptide and atrial natriuretic peptide plasma concentrations during hemodialysis in patients with chronic renal failure.
    Haug C, Metzele A, Steffgen J, Grünert A.
    Horm Metab Res; 1994 May; 26(5):246-9. PubMed ID: 8076909
    [Abstract] [Full Text] [Related]

  • 10. [Is the plasma ANP level an index of volume expansion in dialysis patients?].
    Talartschik J, Eisenhauer T, Voth E, Sold G, Scheler F.
    Z Kardiol; 1988 May; 77 Suppl 2():72-7. PubMed ID: 2970178
    [Abstract] [Full Text] [Related]

  • 11. Exaggerated responsiveness of immunoreactive atrial natriuretic peptide to saline infusion in chronic renal failure.
    Walker RG, Swainson CP, Yandle TG, Nicholls MG, Espiner EA.
    Clin Sci (Lond); 1987 Jan; 72(1):19-24. PubMed ID: 2948753
    [Abstract] [Full Text] [Related]

  • 12. Delayed decrease in plasma levels of atrial natriuretic peptide during cold hemodialysis.
    Hegbrant J, Thysell H, Mårtensson L, Nielsen AL, Lindberg BF.
    Nephron; 1994 Jan; 68(4):427-32. PubMed ID: 7870226
    [Abstract] [Full Text] [Related]

  • 13. Plasma vasopressin, catecholamines and atrial natriuretic factor during hemodialysis and sequential ultrafiltration.
    Os I, Nordby G, Lyngdal PT, Eide I.
    Scand J Urol Nephrol; 1993 Jan; 27(1):93-9. PubMed ID: 8493477
    [Abstract] [Full Text] [Related]

  • 14. Plasma levels of atrial natriuretic peptide and digoxin-like immunoreactive substances in intermittent peritoneal dialysis.
    Korzets Z, Pomeranz M, Shilo L, Pomeranze A, Levi A, Shenkman L, Berheim J.
    Adv Perit Dial; 1989 Jan; 5():20-3. PubMed ID: 2577411
    [Abstract] [Full Text] [Related]

  • 15. Endothelin and atrial natriuretic peptide in non-insulin-dependent diabetic versus nondiabetic patients on chronic hemodialysis.
    Schleiffer T, Nagel D, Franz H, Falk M, Valentiner I, Wildburg G, Stark M, Brass H.
    Ren Fail; 1994 Nov; 16(6):747-58. PubMed ID: 7899586
    [Abstract] [Full Text] [Related]

  • 16. Plasma levels of atrial natriuretic peptide (ANP) in volume expanded patients: response to fluid removal by continuous pump driven hemofiltration.
    Hartter E, Pacher R, Frass M, Woloszczuk W, Leithner C.
    Klin Wochenschr; 1986 Nov; 64 Suppl 6():112-4. PubMed ID: 2948057
    [Abstract] [Full Text] [Related]

  • 17. Plasma atrial natriuretic peptide in patients with chronic renal failure.
    Chen JH, Tsai JH, Lai YH, Hwang SJ.
    J Formos Med Assoc; 1990 Aug; 89(8):645-50. PubMed ID: 1981224
    [Abstract] [Full Text] [Related]

  • 18. Echocardiographic hemodynamic study during ultrafiltration sequential dialysis.
    Cini G, Camici M, Pentimone F, Palla R.
    Nephron; 1982 Aug; 30(2):124-30. PubMed ID: 7099320
    [Abstract] [Full Text] [Related]

  • 19. Influence of hemodialysis on intravascular volume and vasoactive hormones.
    Katzarski KS, Randmaa I, Bergström J.
    Clin Nephrol; 1999 Nov; 52(5):304-11. PubMed ID: 10584994
    [Abstract] [Full Text] [Related]

  • 20. Haemodialysis arteriovenous access--a prospective haemodynamic evaluation.
    Ori Y, Korzets A, Katz M, Perek Y, Zahavi I, Gafter U.
    Nephrol Dial Transplant; 1996 Jan; 11(1):94-7. PubMed ID: 8649659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.